JP2011511944A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511944A5
JP2011511944A5 JP2010546298A JP2010546298A JP2011511944A5 JP 2011511944 A5 JP2011511944 A5 JP 2011511944A5 JP 2010546298 A JP2010546298 A JP 2010546298A JP 2010546298 A JP2010546298 A JP 2010546298A JP 2011511944 A5 JP2011511944 A5 JP 2011511944A5
Authority
JP
Japan
Prior art keywords
ratio
load
subject
plgf
arteriosclerotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010546298A
Other languages
English (en)
Japanese (ja)
Other versions
JP5369118B2 (ja
JP2011511944A (ja
Filing date
Publication date
Priority claimed from EP08151376A external-priority patent/EP2090891A1/en
Application filed filed Critical
Publication of JP2011511944A publication Critical patent/JP2011511944A/ja
Publication of JP2011511944A5 publication Critical patent/JP2011511944A5/ja
Application granted granted Critical
Publication of JP5369118B2 publication Critical patent/JP5369118B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010546298A 2008-02-13 2009-02-09 バイオマーカーｐｌｇｆを用いてアテローム性動脈硬化負荷を決定する手段及び方法 Expired - Fee Related JP5369118B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08151376A EP2090891A1 (en) 2008-02-13 2008-02-13 Means and methods for determining the atherosclerotic load using the biomarker PLGF
EP08151376.4 2008-02-13
PCT/EP2009/051420 WO2009101037A1 (en) 2008-02-13 2009-02-09 Means and methods for determining the atherosclerosis load using the biomarker plgf

Publications (3)

Publication Number Publication Date
JP2011511944A JP2011511944A (ja) 2011-04-14
JP2011511944A5 true JP2011511944A5 (enExample) 2011-07-07
JP5369118B2 JP5369118B2 (ja) 2013-12-18

Family

ID=39183148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010546298A Expired - Fee Related JP5369118B2 (ja) 2008-02-13 2009-02-09 バイオマーカーｐｌｇｆを用いてアテローム性動脈硬化負荷を決定する手段及び方法

Country Status (4)

Country Link
US (1) US20100273268A1 (enExample)
EP (2) EP2090891A1 (enExample)
JP (1) JP5369118B2 (enExample)
WO (1) WO2009101037A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2478371B1 (en) * 2009-09-17 2016-05-04 Roche Diagnostics GmbH Multimarker panel for left ventricular hypertrophy
EP2367006A1 (en) 2010-08-24 2011-09-21 Roche Diagnostics GmbH PLGF-based means and methods for diagnosing cardiac causes in acute inflammation
WO2012066140A1 (en) * 2010-11-19 2012-05-24 Roche Diagnostics Gmbh Method for monitoring physical training in healthy and diseased individuals
CN105451758A (zh) * 2013-05-31 2016-03-30 科比欧尔斯公司 用于心力衰竭的预防或治疗的人plgf-2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US20050154407A1 (en) * 2000-12-20 2005-07-14 Fox Hollow Technologies, Inc. Method of evaluating drug efficacy for treating atherosclerosis
CA2509063C (en) * 2002-11-16 2010-11-02 Dade Behring Marburg Gmbh Scd40l and placental growth factor (plgf) as biochemical marker combinations in cardiovascular diseases
US20050272098A1 (en) * 2004-04-23 2005-12-08 Tramontano Anthony F Quantitation of endothelial microparticles
ES2288718T3 (es) * 2004-07-07 2008-01-16 F. Hoffmann-La Roche Ag Panel de multiples marcadores para la diabetes de tipo 1 y de tipo 2.
DE102004051847B4 (de) * 2004-10-25 2008-09-18 Dade Behring Marburg Gmbh Verhältnis von PIGF und Flt-1 als prognostischer Parameter bei kardio-vaskulären Erkrankungen

Similar Documents

Publication Publication Date Title
Szefler et al. Asthma outcomes: biomarkers
JP2012211908A5 (enExample)
ATE526869T1 (de) Hydratationsmonitor
JP2005509161A5 (enExample)
PL2386860T3 (pl) Przewidywanie śmiertelności i wykrywanie poważnej choroby
BR112013006764A2 (pt) método para avaliar um paciente, kit, meio legível por computador, método para avaliar um tratamento, método para avaliar o risco de um paciente, método para monitorar, método de diagnosticar, sistema de teste, método para classificar ou agrupar uma população de indivíduos, método para avaliar um desfecho substituto, método para tratar, uso de pelo menos um biomarcador, uso de um agente
JP2011506917A5 (enExample)
WO2011070577A3 (en) An ovulation sensing and analyzing system
WO2005048823A3 (en) Modeling of systemic inflammatory response to infection
JP2019500619A5 (enExample)
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
JP2011511944A5 (enExample)
TW200745554A (en) Diagnostic methods using magnetic nanoparticles
JP2008046129A5 (enExample)
JP2010540911A5 (enExample)
Antus et al. Assessment of exhaled nitric oxide by a new hand-held device
MX2012007009A (es) Método para diagnosticar un tumor maligno.
O'Brien et al. An initial evaluation of a proof-of-concept 128-Hz electronic tuning fork in the detection of peripheral neuropathy
WO2010076556A3 (en) A conductivity measurement cell
JP2013504766A5 (enExample)
JP2011528797A5 (enExample)
Carvalho et al. A new hand-held optical reflectometer to measure enamel erosion: correlation with surface hardness and calcium release
JP2008292476A5 (enExample)
JP2007248395A5 (enExample)
JP2006508326A5 (enExample)